Preventing Cognitive Decline and Dementia

Preventing Cognitive Decline and Dementia

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2017-10-05

Total Pages: 181

ISBN-13: 0309459591

DOWNLOAD EBOOK

Societies around the world are concerned about dementia and the other forms of cognitive impairment that affect many older adults. We now know that brain changes typically begin years before people show symptoms, which suggests a window of opportunity to prevent or delay the onset of these conditions. Emerging evidence that the prevalence of dementia is declining in high-income countries offers hope that public health interventions will be effective in preventing or delaying cognitive impairments. Until recently, the research and clinical communities have focused primarily on understanding and treating these conditions after they have developed. Thus, the evidence base on how to prevent or delay these conditions has been limited at best, despite the many claims of success made in popular media and advertising. Today, however, a growing body of prevention research is emerging. Preventing Cognitive Decline and Dementia: A Way Forward assesses the current state of knowledge on interventions to prevent cognitive decline and dementia, and informs future research in this area. This report provides recommendations of appropriate content for inclusion in public health messages from the National Institute on Aging.


Mild Cognitive Impairment

Mild Cognitive Impairment

Author: Ronald C. Petersen

Publisher: Oxford University Press

Published: 2003-01-09

Total Pages: 286

ISBN-13: 0198028741

DOWNLOAD EBOOK

What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions about this condition and its underlying neuropathology remain open, full clinical trials are currently underway worldwide aimed at preventing the progression from MCI to Alzheimer's disease. This book addresses the spectrum of issues involved in mild cognitive impairment, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for clinicians, researchers, and students interested in aging and cognition, among them neurologists, psychiatrists, geriatricians, clinical psychologists, and neuropsychologists.


Alternative Treatments of Dementia and Mild Cognitive Impairment

Alternative Treatments of Dementia and Mild Cognitive Impairment

Author: James Lake MD

Publisher: James Lake

Published: 2015-07-30

Total Pages: 142

ISBN-13:

DOWNLOAD EBOOK

This book is offered as a practical resource on safe, effective and affordable alternative treatments of dementia and mild cognitive impairment (MCI). If you or a loved one are struggling with Alzheimer’s disease (or another type of dementia) or mild cognitive impairment (MCI) this book provides valuable information about non-medication alternatives including lifestyle changes such as exercise and nutrition, herbals and other natural supplements, meditation and mind-body practices and many others. This book is written to give you the maximum amount of information in the least amount of time. From the contents you can instantly navigate to sections that will help you: • Understand dementia better • Take inventory of your symptoms • Identify treatments that make sense for you based on the research evidence • Learn about alternative treatments of dementia and mild cognitive impairment • Develop a customized treatment plan that is right for you • Re-evaluate your treatment plan and make changes if your initial plan doesn’t work If you are a mental health professional this book provides concise, jargon-free summaries of alternative treatments of dementia and mild cognitive impairment. An appendix with links to valuable internet resources is included to help you find quality brands of natural supplements and important safety information. This book is part of a series on alternative and integrative treatments of mental health problems. Other books in the series cover: · Alcohol and drug abuse · Anxiety · Attention Deficit Hyperactivity Disorder (ADHD) · Bipolar disorder · Depression · Insomnia · Post-traumatic stress disorder (PTSD) · Schizophrenia


Neurology in Clinical Practice

Neurology in Clinical Practice

Author: Walter George Bradley

Publisher:

Published: 2004

Total Pages: 1672

ISBN-13: 9780750674690

DOWNLOAD EBOOK

New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.


Ferri's Clinical Advisor 2019 E-Book

Ferri's Clinical Advisor 2019 E-Book

Author: Fred F. Ferri

Publisher: Elsevier Health Sciences

Published: 2018-05-26

Total Pages: 7409

ISBN-13: 0323550762

DOWNLOAD EBOOK

Updated annually with the latest developments in diagnosis and treatment recommendations, Ferri’s Clinical Advisor uses the popular "5 books in 1" format to organize vast amounts of information in a clinically relevant, user-friendly manner. This efficient, intuitive format provides quick access to answers on more than 900 common medical conditions, including diseases and disorders, differential diagnoses, and laboratory tests – all updated by experts in key clinical fields. Updated algorithms and current clinical practice guidelines help you keep pace with the speed of modern medicine. Contains significant updates throughout, with more than 500 new figures, tables, and boxes added to this new edition. Features 17 all-new topics including opioid overdose, obesity-Hypoventilation syndrome, acute pelvic pain in women, new-onset seizures, and eosinophilic esophagitis, among many others. Provides current ICD-10 insurance billing codes to help expedite insurance reimbursements. Includes cross-references, outlines, bullets, tables, boxes, and algorithms to help you navigate a wealth of clinical information. Offers access to exclusive online content: more than 90 additional topics; new algorithms, images, and tables; EBM boxes; patient teaching guides, color images, and more.


Biomarkers in Alzheimer's Disease

Biomarkers in Alzheimer's Disease

Author: Tapan Khan

Publisher: Academic Press

Published: 2016-08-02

Total Pages: 278

ISBN-13: 0128051477

DOWNLOAD EBOOK

Biomarkers in Alzheimer's Disease provides a comprehensive overview of all modalities of Alzheimer's disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer's disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's disease, and for differential diagnosis of Alzheimer's disease with other non-Alzheimer's dementia. - Presents a comprehensive overview detailing all modalities of Alzheimer's disease biomarkers - Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer's Disease - Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer's disease and the technological advancement of biomarkers techniques


Reducing the Impact of Dementia in America

Reducing the Impact of Dementia in America

Author: National Academies of Sciences Engineering and Medicine

Publisher:

Published: 2022-04-26

Total Pages:

ISBN-13: 9780309495035

DOWNLOAD EBOOK

As the largest generation in U.S. history - the population born in the two decades immediately following World War II - enters the age of risk for cognitive impairment, growing numbers of people will experience dementia (including Alzheimer's disease and related dementias). By one estimate, nearly 14 million people in the United States will be living with dementia by 2060. Like other hardships, the experience of living with dementia can bring unexpected moments of intimacy, growth, and compassion, but these diseases also affect people's capacity to work and carry out other activities and alter their relationships with loved ones, friends, and coworkers. Those who live with and care for individuals experiencing these diseases face challenges that include physical and emotional stress, difficult changes and losses in their relationships with life partners, loss of income, and interrupted connections to other activities and friends. From a societal perspective, these diseases place substantial demands on communities and on the institutions and government entities that support people living with dementia and their families, including the health care system, the providers of direct care, and others. Nevertheless, research in the social and behavioral sciences points to possibilities for preventing or slowing the development of dementia and for substantially reducing its social and economic impacts. At the request of the National Institute on Aging of the U.S. Department of Health and Human Services, Reducing the Impact of Dementia in America assesses the contributions of research in the social and behavioral sciences and identifies a research agenda for the coming decade. This report offers a blueprint for the next decade of behavioral and social science research to reduce the negative impact of dementia for America's diverse population. Reducing the Impact of Dementia in America calls for research that addresses the causes and solutions for disparities in both developing dementia and receiving adequate treatment and support. It calls for research that sets goals meaningful not just for scientists but for people living with dementia and those who support them as well. By 2030, an estimated 8.5 million Americans will have Alzheimer's disease and many more will have other forms of dementia. Through identifying priorities social and behavioral science research and recommending ways in which they can be pursued in a coordinated fashion, Reducing the Impact of Dementia in America will help produce research that improves the lives of all those affected by dementia.


White Matter Dementia

White Matter Dementia

Author: Christopher M. Filley

Publisher: Cambridge University Press

Published: 2016-04-28

Total Pages: 231

ISBN-13: 1107035414

DOWNLOAD EBOOK

Presenting the novel concept of white matter dementia, this unique book offers hope for a better understanding and treatment of dementia.


Language in Dementia

Language in Dementia

Author: Louise Cummings

Publisher: Cambridge University Press

Published: 2020-10

Total Pages: 355

ISBN-13: 1108476317

DOWNLOAD EBOOK

Using linguistic data, this book examines language and communication in dementias and their clinical treatment by language pathologists.


Alzheimer’s Disease - From Basic Research to Clinical Applications

Alzheimer’s Disease - From Basic Research to Clinical Applications

Author: Hermann J. Gertz

Publisher: Springer Science & Business Media

Published: 2013-06-29

Total Pages: 313

ISBN-13: 3709175089

DOWNLOAD EBOOK

As human longevity continues to be extended, so will the impact of age-associated dementia on individual lives and society. Alzheimer’s disease as the most common cause of dementia in the elderly remains a sentinal problem and its underlying pathology is still poorly understood. Available therapeutic strategies require considerable refinement and the development of new therapeutic strategies need input from basic research. Thus continued efforts are necessary both to understand basic mechanisms of the condition and to achieve more powerfull therapies. This volume brings together the reports of basic scientists and clinical investigators. The chapters provide a spectrum of information valuable for clinicians and scientists. This issue bridges the gap between laboratory work in basic science and the development of urgently needed therapeutic strategies. Areas presented are the molecular and cellular biology of the disease, pathogenetic mechanisms and potential therapeutic targets, genetics, risk factors, strategies of prevention and treatment as well as practical aspects of medical and social care for patients with Alzheimer’s disease.